- Home
- RAPT vs HOV Comparison
RAPT vs HOV Comparison
Compare RAPT & HOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RAPT | HOV |
|---|---|---|
| Founded | 2015 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.4M | 594.5M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | RAPT | HOV |
|---|---|---|
| Price | $35.21 | $123.10 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | $57.00 | ★ $120.00 |
| AVG Volume (30 Days) | ★ 365.9K | 98.0K |
| Earning Date | 03-05-2026 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.43 |
| Revenue | N/A | ★ $2,978,581,000.00 |
| Revenue This Year | N/A | $7.30 |
| Revenue Next Year | N/A | $4.88 |
| P/E Ratio | ★ N/A | $16.55 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.67 | $81.15 |
| 52 Week High | $42.39 | $162.06 |
Technical Indicators
Market Signals| Indicator | RAPT | HOV |
|---|---|---|
| Relative Strength Index (RSI) | 55.37 | 62.50 |
| Support Level | $33.01 | $119.80 |
| Resistance Level | $35.42 | $127.61 |
| Average True Range (ATR) | 2.17 | 5.30 |
| MACD | 0.03 | 3.35 |
| Stochastic Oscillator | 83.95 | 85.85 |
Price Performance
Historical ComparisonAbout RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About HOV Hovnanian Enterprises Inc.
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations. The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments: Northeast, which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia; Southeast, which includes Florida, Georgia, and South Carolina; and West, which includes Arizona, California, and Texas. The firm generates maximum revenue from the West Segment.